Direct-Vision Stenting: The Way Forward for Malignant Oesophageal Obstruction

Background and Study Aims: Self-expanding metallic stents now form the mainstay of treatment for palliation of dysphagia in oesophageal cancer. These stents are generally inserted under fluoroscopic guidance. However, both the internal and external marking of the tumour can be inaccurate and time-consuming, and access to fluoroscopic facilities is sometimes limited. We prospectively assessed the use of a method of stent insertion under direct vision without the aid of fluoroscopy.
Patients and Methods: A total of 50 consecutive patients presenting with obstructive symptoms secondary to inoperable oesophageal cancers were included in the study. We used either the 7-cm or the 11-cm covered Choo stent (MI-Tech Ltd., Seoul, South Korea).
Results. A total of 52 stents were inserted under direct vision. The procedure generally took less than 15 minutes and good palliation was achieved without complications. Fluoroscopic assistance was required in only one patient.
Conclusions: Direct-vision stent insertion is simple, safe, effective, and only rarely requires fluoroscopic assistance. The technique may be of particular use in centres with limited access to fluoroscopy.

References

• 1 Cowling M G, Hale H, Grundy A. Management of malignant oesophageal obstruction with self-expanding metallic stents.  Br J Surg. 1998;  85 264-266
• 2 Northern Ireland Cancer Registry and National Cancer Registry, Ireland .All Ireland cancer statistics, 1994 - 96. Northern Ireland Cancer Registry and National Cancer Registry, Irelandwww.qub.ac.uk/nicr/statspages/newstables/oeso-incid.html www.nicr.ie/pubs/report-1998.shtml
• 3 Faivre J, Forman D, Esteve J. et al . Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE Working Group.  Eur J Cancer. 1998;  34 2167-2175
• 4 Quint L E, Hepburn L M, Francis I R. et al . Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma.  Cancer. 1995;  76 1120-1125
• 5 Clements W D, Johnston L R, McIlwrath E. et al . Self-expanding metal stents for malignant dysphagia.  J R Soc Med. 1996;  89 454-456
• 6 Taal B G, Kooyman W M, Boot H. Expandable stents compared to conventional plastic endoprostheses in malignant oesophageal obstruction, especially in cardiac cancer and fistulas: the experience of the Netherlands Cancer Institute.  Eur J Gastroenterol Hepatol. 1998;  10 745-752
• 7 Adler D G, Baron T H. Endoscopic palliation of malignant dysphagia.  Mayo Clin Proc. 2001;  76 731-738
• 8 Watkinson A F, Ellul J, Entwisle K. et al . Esophageal carcinoma: initial results of palliative treatment with covered self-expanding endoprostheses.  Radiology. 1995;  195 821-827
• 9 O’Sullivan G J, Grundy A. Palliation of malignant dysphagia with expanding metallic stents.  J Vasc Interv Radiol. 1999;  10 346-351
• 10 Morgan R, Adam A. The radiologist’s view of expandable metallic stents for malignant oesophageal obstruction.  Gastrointest Endosc Clin N Am. 1999;  9 431-435
• 11 Singhvi R, Abbasakoor F, Manson J M. Insertion of self-expanding metal stents for malignant dysphagia: assessment of a simple endoscopic method.  Ann R Coll Surg Engl. 2000;  82 243-248
• 12 White R E, Mungatana C, Topazian M. Esophageal stent placement without fluoroscopy.  Gastrointest Endosc. 2001;  53 348-351
• 13 Austin A S, Khan Z, Cole A T. et al . Placement of esophageal self-expanding metallic stents without fluoroscopy.  Gastrointest Endosc. 2001;  54 357-359